<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37893042</PMID><DateRevised><Year>2023</Year><Month>10</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9059</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>28</Day></PubDate></JournalIssue><Title>Biomedicines</Title><ISOAbbreviation>Biomedicines</ISOAbbreviation></Journal><ArticleTitle>Animals Experimentally Infected with SARS-CoV-2 Generate Functional Autoantibodies against G-Protein-Coupled Receptors.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2668</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biomedicines11102668</ELocationID><Abstract><AbstractText>(1) Background: SARS-CoV-2 infection has been linked to diverse clinical manifestations in humans, including cardiovascular complications. Functional autoantibodies targeting G-protein-coupled receptors have emerged as potential contributors to these effects. This study sought to investigate the production and activity of functional autoantibodies targeting G-protein-coupled receptors after SARS-CoV-2 infection of selected animal species. (2) Methods: The presence of functional autoantibodies such as 2-adrenoceptor, angiotensin II AT1 receptor, muscarinic M2 receptor, and angiotensin 1-7 MAS receptor was assessed in cattle and ferrets experimentally infected with SARS-CoV-2. Bioassays were conducted to evaluate the positive or negative chronotropic responses induced by these autoantibodies. Further experiments identified the extracellular domains to which the functional autoantibodies bind, and receptor antagonists were employed to block the induced responses. (3) Results: Only two out of six cattle that were inoculated with SARS-CoV-2 displayed viral replication and tested positive for functional autoantibodies against G-protein-coupled receptors. These functional autoantibodies specifically recognized &#x3b2;2-adrenoceptor, angiotensin II AT1 receptor, muscarinic M2 receptor, and angiotensin 1-7 MAS receptor and induced distinct positive and negative chronotropic effects in the bioassay. Infected ferrets generated functional autoantibodies against &#x3b2;2-adrenoceptor and muscarinic M2 receptor and presented bioactivity similar to that in cattle. (4) Conclusions: This study uncovers functional autoantibodies targeting G-protein-coupled receptors in cattle and ferrets post-SARS-CoV-2 infection, with implications for cardiovascular function.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wallukat</LastName><ForeName>Gerd</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Berlin Cures GmbH, 13125 Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wernike</LastName><ForeName>Kerstin</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-8071-0827</Identifier><AffiliationInfo><Affiliation>Friedrich-Loeffler-Institut, 17493 Greifswald-Insel Riems, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bachamanda Somesh</LastName><ForeName>Dipthi</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-4129-0804</Identifier><AffiliationInfo><Affiliation>Berlin Heals, 10719 Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mettenleiter</LastName><ForeName>Thomas C</ForeName><Initials>TC</Initials><Identifier Source="ORCID">0000-0002-8385-7899</Identifier><AffiliationInfo><Affiliation>Friedrich-Loeffler-Institut, 17493 Greifswald-Insel Riems, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xfc;ller</LastName><ForeName>Johannes</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Berlin Cures GmbH, 13125 Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Berlin Heals, 10719 Berlin, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomedicines</MedlineTA><NlmUniqueID>101691304</NlmUniqueID><ISSNLinking>2227-9059</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">G-protein-coupled receptors</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">autoantibodies</Keyword><Keyword MajorTopicYN="N">immune response</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword><Keyword MajorTopicYN="N">viral infection</Keyword></KeywordList><CoiStatement>Authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>28</Day><Hour>11</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>28</Day><Hour>11</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>28</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37893042</ArticleId><ArticleId IdType="pmc">PMC10604621</ArticleId><ArticleId IdType="doi">10.3390/biomedicines11102668</ArticleId><ArticleId IdType="pii">biomedicines11102668</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Liu J., Li S., Liu J., Liang B., Wang X., Wang H., Li W., Tong Q., Yi J., Zhao L., et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine. 2020;55:102763. doi: 10.1016/j.ebiom.2020.102763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.102763</ArticleId><ArticleId IdType="pmc">PMC7165294</ArticleId><ArticleId IdType="pubmed">32361250</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Dyer A.H., Jones K., Dunne J., Mooney A., Gaffney F., O&#x2019;Connor L., Leavy D., O&#x2019;Brien K., Dowds J., et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS ONE. 2020;15:e0240784. doi: 10.1371/journal.pone.0240784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0240784</ArticleId><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;Em Y., Redfield S., Austin J.P., Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang E.Y., Mao T., Klein J., Dai Y., Huck J.D., Jaycox J.R., Liu F., Zhou T., Israelow B., Wong P., et al. Diverse Functional Autoantibodies in Patients with COVID-19. Nature. 2021;595:283&#x2013;288. doi: 10.1038/s41586-021-03631-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabral-Marques O., Halpert G., Schimke L.F., Ostrinski Y., Vojdani A., Baiocchi G.C., Freire P.P., Filgueiras I.S., Zyskind I., Lattin M.T., et al. Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity. Nat. Commun. 2022;13:1220. doi: 10.1038/s41467-022-28905-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-28905-5</ArticleId><ArticleId IdType="pmc">PMC8907309</ArticleId><ArticleId IdType="pubmed">35264564</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallukat G., Hohberger B., Wenzel K., F&#xfc;rst J., Schulze-Rothe S., Wallukat A., H&#xf6;nicke A.-S., M&#xfc;ller J. Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms. J. Transl. Autoimmun. 2021;4:100100. doi: 10.1016/j.jtauto.2021.100100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtauto.2021.100100</ArticleId><ArticleId IdType="pmc">PMC8049853</ArticleId><ArticleId IdType="pubmed">33880442</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallukat G., Wollenberger A., Morwinski R., Pitschner H. Anti-beta 1-adrenoceptor autoantibodies with chronotropic activity from the serum of patients with dilated cardiomyopathy: Mapping of epitopes in the first and second extracellular loops. J. Mol. Cell. Cardiol. 1995;27:397&#x2013;406. doi: 10.1016/S0022-2828(08)80036-3. Correction in J. Mol. Cell. Cardiol.&#xa0;1995, 27, 2529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-2828(08)80036-3</ArticleId><ArticleId IdType="pubmed">7539084</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#xfc;nemann A., Hohberger B., Rech J., Sheriff A., Fu Q., Schl&#xf6;tzer-Schrehardt U., Voll R.E., Bartel S., Kalbacher H., Hoebeke J., et al. Agonistic Autoantibodies to the &#x3b2;2-Adrenergic Receptor Involved in the Pathogenesis of Open-Angle Glaucoma. Front. Immunol. 2018;9:145. doi: 10.3389/fimmu.2018.00145.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00145</ArticleId><ArticleId IdType="pmc">PMC5816038</ArticleId><ArticleId IdType="pubmed">29483909</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallukat G., Schimke I. Agonistic autoantibodies directed against G-protein-coupled receptors and their relationship to cardiovascular diseases. Semin. Immunopathol. 2014;36:351&#x2013;363. doi: 10.1007/s00281-014-0425-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-014-0425-9</ArticleId><ArticleId IdType="pubmed">24777744</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulrich L., Wernike K., Hoffmann D., Mettenleiter T.C., Beer M. Experimental Infection of Cattle with SARS-CoV-2. Emerg. Infect. Dis. 2020;26:2979&#x2013;2981. doi: 10.3201/eid2612.203799.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2612.203799</ArticleId><ArticleId IdType="pmc">PMC7706945</ArticleId><ArticleId IdType="pubmed">33034284</ArticleId></ArticleIdList></Reference><Reference><Citation>Falkenberg S., Buckley A., Laverack M., Martins M., Palmer M.V., Lager K., Diel D.G. Experimental Inoculation of Young Calves with SARS-CoV-2. Viruses. 2021;13:441. doi: 10.3390/v13030441.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13030441</ArticleId><ArticleId IdType="pmc">PMC8000368</ArticleId><ArticleId IdType="pubmed">33803455</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlottau K., Rissmann M., Graaf A., Sch&#xf6;n J., Sehl J., Wylezich C., H&#xf6;per D., Mettenleiter T.C., Balkema-Buschmann A., Harder T., et al. SARS-CoV-2 in fruit bats, ferrets, pigs, and chickens: An experimental transmission study. Lancet Microbe. 2020;1:e218&#x2013;e225. doi: 10.1016/S2666-5247(20)30089-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(20)30089-6</ArticleId><ArticleId IdType="pmc">PMC7340389</ArticleId><ArticleId IdType="pubmed">32838346</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard M., Kok A., De Meulder D., Bestebroer T.M., Lamers M.M., Okba N.M.A., Van Vlissingen M.F., Rockx B., Haagmans B.L., Koopmans M., et al. SARS-CoV-2 is transmitted via contact and via the air between ferrets. Nat. Commun. 2020;11:3496. doi: 10.1038/s41467-020-17367-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17367-2</ArticleId><ArticleId IdType="pmc">PMC7343828</ArticleId><ArticleId IdType="pubmed">32641684</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi J., Wen Z., Zhong G., Yang H., Wang C., Huang B., Liu R., He X., Shuai L., Sun Z., et al. Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2. Science. 2020;368:1016&#x2013;1020. doi: 10.1126/science.abb7015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb7015</ArticleId><ArticleId IdType="pmc">PMC7164390</ArticleId><ArticleId IdType="pubmed">32269068</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulit-Penaloza J.A., Belser J.A., Sun X., Pappas C., Brock N., Kieran T.J., Ritter J.M., Seixas J.N., Jones J., Thakur P.B., et al. Comparative Assessment of Severe Acute Respiratory Syndrome Coronavirus 2 Variants in the Ferret Model. mBio. 2022;13:e0242122. doi: 10.1128/mbio.02421-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mbio.02421-22</ArticleId><ArticleId IdType="pmc">PMC9600705</ArticleId><ArticleId IdType="pubmed">36135377</ArticleId></ArticleIdList></Reference><Reference><Citation>Barut G.T., Halwe N.J., Taddeo A., Kelly J.N., Sch&#xf6;n J., Ebert N., Ulrich L., Devisme C., Steiner S., Tr&#xfc;eb B.S., et al. The spike gene is a major determinant for the SARS-CoV-2 Omicron-BA.1 phenotype. Nat. Commun. 2022;13:5929. doi: 10.1038/s41467-022-33632-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-33632-y</ArticleId><ArticleId IdType="pmc">PMC9543931</ArticleId><ArticleId IdType="pubmed">36207334</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Perez A.I., Labandeira C.M., Pedrosa M.A., Valenzuela R., Suarez-Quintanilla J.A., Cortes-Ayaso M., May&#xe1;n-Conesa P., Labandeira-Garcia J.L. Autoantibodies against ACE2 and angiotensin type-1 receptors increase severity of COVID-19. J. Autoimmun. 2021;122:102683. doi: 10.1016/j.jaut.2021.102683.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2021.102683</ArticleId><ArticleId IdType="pmc">PMC8193025</ArticleId><ArticleId IdType="pubmed">34144328</ArticleId></ArticleIdList></Reference><Reference><Citation>Vakil M.K., Mansoori Y., Al-Awsi G.R.L., Hosseinipour A., Ahsant S., Ahmadi S., Ekrahi M., Montaseri Z., Pezeshki B., Mohaghegh P., et al. Individual genetic variability mainly of Proinflammatory cytokines, cytokine receptors, and toll-like receptors dictates pathophysiology of COVID-19 disease. J. Med. Virol. 2022;94:4088&#x2013;4096. doi: 10.1002/jmv.27849.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27849</ArticleId><ArticleId IdType="pmc">PMC9348290</ArticleId><ArticleId IdType="pubmed">35538614</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B., Huang S., Yin L. The cytokine storm and COVID-19. J. Med. Virol. 2021;93:250&#x2013;256. doi: 10.1002/jmv.26232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26232</ArticleId><ArticleId IdType="pmc">PMC7361342</ArticleId><ArticleId IdType="pubmed">32592501</ArticleId></ArticleIdList></Reference><Reference><Citation>Hojyo S., Uchida M., Tanaka K., Hasebe R., Tanaka Y., Murakami M., Hirano T. How COVID-19 induces cytokine storm with high mortality. Inflamm. Regen. 2020;40:37. doi: 10.1186/s41232-020-00146-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41232-020-00146-3</ArticleId><ArticleId IdType="pmc">PMC7527296</ArticleId><ArticleId IdType="pubmed">33014208</ArticleId></ArticleIdList></Reference><Reference><Citation>Montazersaheb S., Khatibi S.M.H., Hejazi M.S., Tarhriz V., Farjami A., Sorbeni F.G., Farahzadi R., Ghasemnejad T. COVID-19 infection: An overview on cytokine storm and related interventions. Virol. J. 2022;19:92. doi: 10.1186/s12985-022-01814-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-022-01814-1</ArticleId><ArticleId IdType="pmc">PMC9134144</ArticleId><ArticleId IdType="pubmed">35619180</ArticleId></ArticleIdList></Reference><Reference><Citation>Ullah R., Khan J., Basharat N., Huo D., Din A.U., Wang G. Evaluation of Cardiac Biomarkers and Expression Analysis of IL-1, IL-6, IL-10, IL-17, and IL-25 among COVID-19 Patients from Pakistan. Viruses. 2022;14:2149. doi: 10.3390/v14102149.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14102149</ArticleId><ArticleId IdType="pmc">PMC9610190</ArticleId><ArticleId IdType="pubmed">36298704</ArticleId></ArticleIdList></Reference><Reference><Citation>LaMarca B., Speed J., Ray L.F., Cockrell K., Wallukat G., Dechend R., Granger J. Hypertension in response to IL-6 during pregnancy: Role of AT1-receptor activation. Int. J. Interf. Cytokine Mediat. Res. 2011;2011:65&#x2013;70. doi: 10.2147/IJICMR.S22329.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJICMR.S22329</ArticleId><ArticleId IdType="pmc">PMC3446210</ArticleId><ArticleId IdType="pubmed">23002372</ArticleId></ArticleIdList></Reference><Reference><Citation>Csobonyeiova M., Smolinska V., Harsanyi S., Ivantysyn M., Klein M. The Immunomodulatory Role of Cell-Free Approaches in SARS-CoV-2-Induced Cytokine Storm&#x2014;A Powerful Therapeutic Tool for COVID-19 Patients. Biomedicines. 2023;11:1736. doi: 10.3390/biomedicines11061736.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11061736</ArticleId><ArticleId IdType="pmc">PMC10295896</ArticleId><ArticleId IdType="pubmed">37371831</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhillion P., Wallace K., Herse F., Scott J., Wallukat G., Heath J., Mosely J., Martin J.N., Dechend R., LaMarca B., et al. IL-17-mediated oxidative stress is an important stimulator of AT1-AA and hypertension during pregnancy. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2012;303:R353&#x2013;R358. doi: 10.1152/ajpregu.00051.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpregu.00051.2012</ArticleId><ArticleId IdType="pmc">PMC3423993</ArticleId><ArticleId IdType="pubmed">22718806</ArticleId></ArticleIdList></Reference><Reference><Citation>Cornelius D.C., Hogg J.P., Scott J., Wallace K., Herse F., Moseley J., Wallukat G., Dechend R., LaMarca B. Administration of interleukin-17 soluble receptor C suppresses TH17 cells, oxidative stress, and hypertension in response to placental ischemia during pregnancy. Hypertension. 2013;62:1068&#x2013;1073. doi: 10.1161/HYPERTENSIONAHA.113.01514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.113.01514</ArticleId><ArticleId IdType="pmc">PMC3899693</ArticleId><ArticleId IdType="pubmed">24060899</ArticleId></ArticleIdList></Reference><Reference><Citation>Cornelius D.C., Lamarca B. TH17- and IL-17- mediated autoantibodies and placental oxidative stress play a role in the pathophysiology of pre-eclampsia. Minerva Ginecol. 2014;66:243&#x2013;249.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5089699</ArticleId><ArticleId IdType="pubmed">24971780</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzgerald S., Deer E., Hogg J., Cornelius D.C., Turner T., Amaral L.M., Hoang N., Edwards K., Herrock O., Campbell N., et al. RUPP Th17s cause hypertension and mitochondrial dysfunction in the kidney and placenta during pregnancy. Pregnancy Hypertens. 2023;32:50&#x2013;56. doi: 10.1016/j.preghy.2023.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.preghy.2023.04.002</ArticleId><ArticleId IdType="pubmed">37104924</ArticleId></ArticleIdList></Reference><Reference><Citation>Cornelius D.C., Amaral L.M., Wallace K., Campbell N., Thomas A.J., Scott J., Herse F., Wallukat G., Dechend R., LaMarca B., et al. Reduced uterine perfusion pressure T-helper 17 cells cause pathophysiology associated with preeclampsia during pregnancy. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2016;311:R1192&#x2013;R1199. doi: 10.1152/ajpregu.00117.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpregu.00117.2016</ArticleId><ArticleId IdType="pmc">PMC5256975</ArticleId><ArticleId IdType="pubmed">27784685</ArticleId></ArticleIdList></Reference><Reference><Citation>Velloso E.P., Pimentel R.L., Braga J.F., Cabral A.C.V., Reis Z.S.N., Bader M., Santos R.A.S., Wallukat G. Identification of a Novel Agonist-Like Autoantibody in Preeclamptic Patients. Am. J. Hypertens. 2016;29:405&#x2013;412. doi: 10.1093/ajh/hpv099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajh/hpv099</ArticleId><ArticleId IdType="pubmed">26158852</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsen S.B., Wallukat G., Schimke I., Sandager A., Christensen T.T., Uldbjerg N., T&#xf8;rring N. Functional autoantibodies against Endothelin-1 receptor type A and Angiotensin II receptor type 1 in patients with preeclampsia. Pregnancy Hypertens. 2018;14:189&#x2013;194. doi: 10.1016/j.preghy.2018.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.preghy.2018.10.002</ArticleId><ArticleId IdType="pubmed">30527110</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y.-I., Kim S.-G., Kim S.-M., Kim E.-H., Park S.-J., Yu K.-M., Chang J.-H., Kim E.J., Lee S., Casel M.A.B., et al. Infection and Rapid Transmission of SARS-CoV-2 in Ferrets. Cell Host Microbe. 2020;27:704&#x2013;709.e2. doi: 10.1016/j.chom.2020.03.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.03.023</ArticleId><ArticleId IdType="pmc">PMC7144857</ArticleId><ArticleId IdType="pubmed">32259477</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohberger B., Harrer T., Mardin C., Kruse F., Hoffmanns J., Rogge L., Heltmann F., Moritz M., Szewczykowski C., Schottenhamml J., et al. Case Report: Neutralization of Autoantibodies Targeting G-Protein-Coupled Receptors Improves Capillary Impairment and Fatigue Symptoms After COVID-19 Infection. Front. Med. 2021;8:754667. doi: 10.3389/fmed.2021.754667.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.754667</ArticleId><ArticleId IdType="pmc">PMC8637609</ArticleId><ArticleId IdType="pubmed">34869451</ArticleId></ArticleIdList></Reference><Reference><Citation>Haberland A., Holtzhauer M., Schlichtiger A., Bartel S., Schimke I., M&#xfc;ller J., Dandel M., Luppa P.B., Wallukat G. Aptamer BC 007&#x2014;A broad spectrum neutralizer of pathogenic autoantibodies against G-protein-coupled receptors. Eur. J. Pharmacol. 2016;789:37&#x2013;45. doi: 10.1016/j.ejphar.2016.06.061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2016.06.061</ArticleId><ArticleId IdType="pubmed">27375076</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>